mk 0852 has been researched along with fibrinogen in 2 studies
| Studies (mk 0852) | Trials (mk 0852) | Recent Studies (post-2010) (mk 0852) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 17 | 2 | 0 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsson, A; Lindahl, TL | 1 |
| Rothe, G; Schmitz, G; Wittig, K | 1 |
2 other study(ies) available for mk 0852 and fibrinogen
| Article | Year |
|---|---|
Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist.
Topics: Animals; Antigen-Antibody Complex; Blood Platelets; Fibrinogen; Flow Cytometry; Humans; Oligopeptides; Peptides, Cyclic; Platelet Membrane Glycoproteins; Rabbits; Thiazolidines | 1994 |
Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Topics: Adult; Blood Platelets; Fibrinogen; Humans; Middle Aged; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Thiazolidines | 1998 |